Trial intelligence / Profile preview

Esomeprazole and Sildenafil in Early-onset Preeclampsia

NCT03724838Unknown

Sponsor
Aswan University Hospital
Start
Dec 2018
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of esomeprazole and ASP-001 in preeclampsia, sponsored by Aswan University Hospital. Primary endpoint: Prolongation of gestation at 3 weeks. Status: unknown.

02

Drugs

esomeprazoleASP-001
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT03724838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03724838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call